MA50195A - Séparation d'anticorps à chaîne triple légère à l'aide d'une chromatographie à échange de cations - Google Patents

Séparation d'anticorps à chaîne triple légère à l'aide d'une chromatographie à échange de cations

Info

Publication number
MA50195A
MA50195A MA050195A MA50195A MA50195A MA 50195 A MA50195 A MA 50195A MA 050195 A MA050195 A MA 050195A MA 50195 A MA50195 A MA 50195A MA 50195 A MA50195 A MA 50195A
Authority
MA
Morocco
Prior art keywords
cation exchange
exchange chromatography
chain antibody
triple chain
antibody separation
Prior art date
Application number
MA050195A
Other languages
English (en)
Inventor
Xinfang Li
Fang Liu
Original Assignee
Immunogen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunogen Inc filed Critical Immunogen Inc
Publication of MA50195A publication Critical patent/MA50195A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244—Interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2866—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/51—Complete heavy chain or Fd fragment, i.e. VH + CH1
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/515—Complete light chain, i.e. VL + CL
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/52—Constant or Fc region; Isotype
    • C07K2317/526—CH3 domain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/565—Complementarity determining region [CDR]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
    • C07K2317/92—Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
MA050195A 2017-09-22 2018-09-21 Séparation d'anticorps à chaîne triple légère à l'aide d'une chromatographie à échange de cations MA50195A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201762562188P 2017-09-22 2017-09-22

Publications (1)

Publication Number Publication Date
MA50195A true MA50195A (fr) 2020-07-29

Family

ID=65810610

Family Applications (1)

Application Number Title Priority Date Filing Date
MA050195A MA50195A (fr) 2017-09-22 2018-09-21 Séparation d'anticorps à chaîne triple légère à l'aide d'une chromatographie à échange de cations

Country Status (12)

Country Link
US (2) US20190112359A1 (fr)
EP (1) EP3684409A4 (fr)
JP (2) JP2020534332A (fr)
KR (1) KR20200056396A (fr)
CN (1) CN111163804A (fr)
AU (1) AU2018338205A1 (fr)
CA (1) CA3073414A1 (fr)
IL (1) IL272849A (fr)
MA (1) MA50195A (fr)
SG (1) SG11202001401TA (fr)
TW (2) TWI826393B (fr)
WO (1) WO2019060718A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113150145B (zh) 2013-08-30 2025-02-14 伊缪诺金公司 用于检测叶酸受体1的抗体和测定
AU2016285552B2 (en) * 2015-06-29 2022-10-13 Immunogen, Inc. Anti-CD123 antibodies and conjugates and derivatives thereof
MA55818A (fr) 2019-04-29 2022-03-16 Immunogen Inc Anticorps et immunoconjugués de fr-alpha biparatopique
KR20220004669A (ko) 2019-04-29 2022-01-11 이뮤노젠 아이엔씨 항-cd123 면역접합체를 포함하는 치료적 조합물
US20220306751A1 (en) 2019-09-13 2022-09-29 Mythic Therapeutics, Inc. Antigen-binding protein constructs and uses thereof
WO2025054312A1 (fr) * 2023-09-05 2025-03-13 Tizona Therapeutics Anticorps hla-g dans des conjugués anticorps-médicament
US20250345449A1 (en) 2024-05-10 2025-11-13 Immunogen, Inc. Anti-cd123 immunoconjugates for the treatment of blastic plasmacytoid cell neoplasm

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5225539A (en) 1986-03-27 1993-07-06 Medical Research Council Recombinant altered antibodies and methods of making altered antibodies
TWI318983B (en) * 2000-05-02 2010-01-01 Uab Research Foundation An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
DK1791565T3 (en) 2004-09-23 2016-08-01 Genentech Inc Cysteingensplejsede antibodies and conjugates
ES2533266T5 (es) * 2007-10-30 2018-04-18 Genentech, Inc. Purificación de anticuerpos mediante cromatografía de intercambio catiónico
BRPI0907046A2 (pt) 2008-01-18 2015-07-28 Medimmune Llc Anticorpo de cisteína engenheirada, ácido nucleico isolado, vetor, célula hospedeira, conjugado de anticorpo, composição farmacêutica, métodos de detecção de câncer, doenças ou distúrbios autoimunes, inflamatórios ou infecciosos em um indivíduo e de inibição de proliferação de uma célula alvo
EP2711018A1 (fr) 2009-06-22 2014-03-26 MedImmune, LLC Régions Fc modifiées pour conjugaison spécifique d'un site
US9650411B2 (en) * 2012-08-07 2017-05-16 Kyowa Hakko Kirin Co., Ltd. Method of purifying protein
RU2699717C2 (ru) * 2014-04-18 2019-09-09 Дзе Ресёч Фаундэйшен Фор Дзе Штат Юниверсити Ов Нью-Йорк Гуманизированные антитела к антигену Томсена-Фриденрайха
SMT202000614T1 (it) * 2015-06-29 2021-01-05 Immunogen Inc Coniugati di anticorpi ingegnerizzati con cisteina
AU2016285552B2 (en) * 2015-06-29 2022-10-13 Immunogen, Inc. Anti-CD123 antibodies and conjugates and derivatives thereof

Also Published As

Publication number Publication date
RU2020107752A3 (fr) 2022-04-27
TW201915011A (zh) 2019-04-16
CN111163804A (zh) 2020-05-15
TW202428598A (zh) 2024-07-16
RU2020107752A (ru) 2021-10-22
CA3073414A1 (fr) 2019-03-28
JP2020534332A (ja) 2020-11-26
WO2019060718A1 (fr) 2019-03-28
US20250236659A1 (en) 2025-07-24
EP3684409A4 (fr) 2021-06-23
EP3684409A1 (fr) 2020-07-29
JP2023112042A (ja) 2023-08-10
KR20200056396A (ko) 2020-05-22
SG11202001401TA (en) 2020-04-29
IL272849A (en) 2020-04-30
US20190112359A1 (en) 2019-04-18
TWI826393B (zh) 2023-12-21
AU2018338205A1 (en) 2020-05-07

Similar Documents

Publication Publication Date Title
EP3684409A4 (fr) Séparation d'anticorps à chaîne triple légère à l'aide d'une chromatographie à échange de cations
EP3329237A4 (fr) Mécanisme statiquement équilibré à l'aide de cylindres de halbach
PL3687994T3 (pl) Środki kontrastowe na bazie pcta zawierające gadolin
SI3864003T1 (sl) Modulatorji predzdravila poti integriranega odziva na stres
EP3491342A4 (fr) Compensation de dérive à l'estime à l'aide de la démarche personnelle
EP3759131A4 (fr) Identification de néo-antigène à l'aide de modèles pan-allèles
EP3642218A4 (fr) Tampon de lavage pour chromatographie d'échange cationique
EP3685350A4 (fr) Reconstruction d'image à l'aide de régularisateurs d'apprentissage machine
PL4088720T3 (pl) Rimegepant na zaburzenia związane z cgrp
EP3539157A4 (fr) Source de lumière à réseau de micro-del multicolore
EP3405247A4 (fr) Administration de botuline à l'aide de matrices de micro-aiguilles
EP3776189A4 (fr) Prédiction précoce précise de branchement dans des microprocesseurs à hautes performances
EP3402519A4 (fr) Constructions de liaison à l'antigène immunomodulateur multispécifique
EP3801869A4 (fr) Microcapsules à surface modifiée
EP3465948A4 (fr) Suivi d'actif à l'aide d'une communication par lumière visible
EP3314205A4 (fr) Technologies pour navigation à l'estime pour piéton
EP3888291A4 (fr) Techniques d'empêchement de collusion à l'aide d'une libération de clé simultanée
EP3746103A4 (fr) Protéines modifiées pour améliorer la sensibilité d'une cellule à l'il-2
EP3843846A4 (fr) Composés de liaison à la fascine pour la spinogenèse
EP3723657A4 (fr) Nettoyage à l'aide de suspension
EP3532804A4 (fr) Détection de position de piston hydraulique/pneumatique tolérant à l'usure à l'aide de capteurs optiques
EP3768309A4 (fr) Glycoconjugués de précision en tant qu'outils thérapeutiques
EP3437646A4 (fr) Préparation orale présentant une exceptionnelle aptitude à l'élution
EP3826783A4 (fr) Liaison destinée à différentes structures coulissant ensemble
EP3311788A4 (fr) Outil d'aide à l'instillation oculaire